# Maravai LifeSciences Holdings, Inc. (MRVI) FY2026 Q2 P&L / Income Statement

- Company: Maravai LifeSciences Holdings, Inc. (MRVI)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-07, accession number 0001823239-26-000059
- Page: https://plicit.ai/financials/mrvi/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/mrvi-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Geography

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 51,442,000 US dollars
- **Cost of revenue**: 30,792,000 US dollars
- **Gross profit**: 20,650,000 US dollars
- **Operating expenses (calculated)**: 35,739,000 US dollars
- **Loss from operations**: negative 15,089,000 US dollars
- **Other income (expense), net (calculated)**: negative 6,713,000 US dollars
- **Loss before income taxes**: negative 21,802,000 US dollars
- **Income tax benefit**: negative 171,000 US dollars
- **Net loss**: negative 21,631,000 US dollars
- **Cygnus - Latin and Central America**: 193,000 US dollars
- **Cygnus - Asia Pacific**: 5,618,000 US dollars
- **Cygnus - North America**: 6,638,000 US dollars
- **Cygnus - Europe, the Middle East and Africa**: 4,324,000 US dollars
- **TriLink - Latin and Central America**: 193,000 US dollars
- **TriLink - Asia Pacific**: 3,701,000 US dollars
- **TriLink - North America**: 24,646,000 US dollars
- **TriLink - Europe, the Middle East and Africa**: 6,129,000 US dollars
- **Selling, general and administrative**: 32,070,000 US dollars
- **Research and development**: 3,702,000 US dollars
- **Goodwill impairment**: 0 US dollars
- **Restructuring**: negative 33,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Maravai LifeSciences Holdings, Inc.: −$12.42 M; to noncontrolling interests: −$9.22 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/mrvi/fy2026-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/mrvi-fy2026-q2-revenue-by-business-segment-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 51,442,000 US dollars
- **Cost of revenue**: 30,792,000 US dollars
- **Gross profit**: 20,650,000 US dollars
- **Operating expenses (calculated)**: 35,739,000 US dollars
- **Loss from operations**: negative 15,089,000 US dollars
- **Other income (expense), net (calculated)**: negative 6,713,000 US dollars
- **Loss before income taxes**: negative 21,802,000 US dollars
- **Income tax benefit**: negative 171,000 US dollars
- **Net loss**: negative 21,631,000 US dollars
- **TriLink**: 34,669,000 US dollars
- **Cygnus**: 16,773,000 US dollars
- **Selling, general and administrative**: 32,070,000 US dollars
- **Research and development**: 3,702,000 US dollars
- **Goodwill impairment**: 0 US dollars
- **Restructuring**: negative 33,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Maravai LifeSciences Holdings, Inc.: −$12.42 M; to noncontrolling interests: −$9.22 M.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/mrvi/fy2026-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/mrvi-fy2026-q2-revenue-by-geography-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 51,442,000 US dollars
- **Cost of revenue**: 30,792,000 US dollars
- **Gross profit**: 20,650,000 US dollars
- **Operating expenses (calculated)**: 35,739,000 US dollars
- **Loss from operations**: negative 15,089,000 US dollars
- **Other income (expense), net (calculated)**: negative 6,713,000 US dollars
- **Loss before income taxes**: negative 21,802,000 US dollars
- **Income tax benefit**: negative 171,000 US dollars
- **Net loss**: negative 21,631,000 US dollars
- **North America**: 31,284,000 US dollars
- **Europe, the Middle East and Africa**: 10,453,000 US dollars
- **Asia Pacific**: 9,319,000 US dollars
- **Latin and Central America**: 386,000 US dollars
- **Selling, general and administrative**: 32,070,000 US dollars
- **Research and development**: 3,702,000 US dollars
- **Goodwill impairment**: 0 US dollars
- **Restructuring**: negative 33,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Maravai LifeSciences Holdings, Inc.: −$12.42 M; to noncontrolling interests: −$9.22 M.